CA Final · Advanced Financial Management · Financial Policy and Corporate Strategy
Which statement best describes the Modigliani-Miller dividend irrelevance proposition in a perfect capital market?
Under MM in a perfect market, firm value is driven by earning power and investment decisions, not by the dividend payout. Investors can create homemade dividends by selling shares or reinvesting, so the split between dividends and retention does not change value.
- AFirm value depends on the dividend payout ratio because investors prefer current income
- BFirm value is determined by earning power and investment policy, not by how earnings are split between dividends and retained earningsCorrect
- CHigher retention always increases share price since the firm can invest at its cost of capital
- DDividends signal management confidence, so a higher payout raises value
Explanation
MM argue that in perfect markets with no taxes, no transaction costs and a fixed investment policy, shareholders can create homemade dividends, so payout does not alter value. The first and fourth options reflect the bird-in-hand and signalling views, which MM reject.
Did you get it right without looking?
One question tells you little. A timed set on Financial Policy and Corporate Strategy shows your real accuracy, how long you take and where you lose marks.
More Financial Policy and Corporate Strategy questions
- Kaveri Engineering Ltd expects earnings per share of Rs 20 this year and follows Walter's model. Its return on investment (r) is 15% and cos…
- Tarang Industries, a diversified Indian group, has a board that decides which businesses to enter or exit, how capital is allocated across i…
- Aarav Pharma has sales of Rs 100 crore, with net profit margin 5% and a dividend payout of 40%. Sales are expected to rise 20% next year. Ex…
- Himalaya Foods Ltd plans a project with an initial outlay of ₹500 lakh. Its target capital structure is 60% equity and 40% debt. The firm ha…
- Anand Textiles Ltd has 10 lakh shares with a market price of Rs 150 and a cost of equity of 12%. It has debt of Rs 600 lakh at a pre-tax cos…
- Vistar Pharma Ltd forecasts next year's sales of ₹600 crore, up from ₹500 crore. Assets that vary with sales are 70% of sales and spontaneou…